Logansport social media was abuzz with excitement Wednesday as news about the Indiana Museum of Art spread through the community. The Indiana Museum of Art, founded by local artist Jason Myers and ...

Two brave adventurers and best friends have joined forced to embark on a once-in-a-lifetime trek from one side of the globe to the other. Luke Deakin set off on an insane trek from his homeland, the ...

"They are a very close family, they spend a lot of time together, and Steven treats Lee just as he would anyone else." ...

LILY Phillips has admitted she is playing roulette when it comes to catching STI’s after bedding 101 men in a day and planning for 1,000. Speaking on The Shizuo Show, ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Eli Lilly (NYSE:LLY) has entered into a licensing agreement with Mediar Therapeutics to advance Mediar's drug MTX-463 into ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions ...

Venture capital firm Andreessen Horowitz said on Friday it was working with Eli Lilly to launch a $500 million venture fund that will be fully funded by the U.S. drugmaker.

A Phase 2 trial of MTX-463 in idiopathic pulmonary fibrosis expected in 1H 2025.

Eli Lilly’s idiopathic pulmonary fibrosis deal with Mediar is centered around MTX-463, an anti-WISP1 antibody that early ...

Eli Lilly is making a play for the idiopathic pulmonary fibrosis (IPF) market, offering Mediar Therapeutics $99 million in ...

Dr. Buchanan will helm Belharra's research organization as the company progresses its lead immunology and oncology programs, advances activities with its pharma collaborators, and enriches its ...